Article Text

Download PDFPDF
Treatment of stiff person syndrome with rituximab
  1. M R Baker1,
  2. M Das1,
  3. J Isaacs3,
  4. P R W Fawcett2,
  5. D Bates1
  1. 1Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
  2. 2Department of Neurophysiology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
  3. 3Department of Rheumatology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
  1. Correspondence to:
 Prof D Bates
 Department of Neurology, Royal Victoria Infirmary Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK; david.batesncl.ac.uk

Abstract

This case report is about the novel use of the anti-CD20 antibody, rituximab, in the treatment of a 41 year old woman with stiff person syndrome. She was admitted to hospital as an emergency with prolonged and painful extensor spasms affecting the neck and back, arms, and legs. The disease had progressed despite a favourable initial response to conventional treatment with intravenous immunoglobulin and cytotoxics. Treatment with rituximab induced a lasting clinical remission.

  • anti-GAD, antiglutamic acid decarboxylase
  • rituximab
  • stiff person
  • syndrome

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: none declared